NYSE$DOCS
Doximity Inc. · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
Doximity reported strong fiscal Q3 2025 results with revenue of $168.6 million, up 25% YoY. Net income surged 57% to $75.2 million, and adjusted EBITDA increased 39% to $102.0 million, reflecting solid profitability and operational efficiency.
Headline financials
Revenue & EPS history
Doximity · Revenue · Quarterly
$169M
Forward guidance
Doximity expects fiscal Q4 2025 revenue between $132.5 million and $133.5 million, with adjusted EBITDA guidance of $62.5 million to $63.5 million. Full-year revenue is projected between $564.6 million and $565.6 million.
Tailwinds
- Strong revenue growth driven by increasing engagement on platform.
- AI tools showing significant adoption with 60% QoQ growth.
- Improved profitability with higher adjusted EBITDA margins.
- Solid free cash flow generation of $63.4 million.
- Expansion in platform usage among medical professionals.
Headwinds
- Projected revenue for Q4 indicates a sequential decline.
- Macroeconomic uncertainty may impact client spending.
- High reliance on subscription revenue with potential churn risks.
- Operating expenses increased YoY across key segments.
- Stock-based compensation remains a significant cost factor.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
+5.5%
Avg return
Earnings day
+2.9%
Avg return
5 days after
+3.3%
Avg return
30 days after
64%
14 / 22 earnings
Positive
+45.6%
Q2 2023
Best reaction
-26.6%
Q1 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +5.3% | -17.6% | -14.3% | |
| Q3 2026 | -16.8% | -22.1% | -23.9% | |
| Q2 2026 | -13.0% | -18.6% | -26.6% | |
| Q1 2026 | +13.4% | +9.3% | +18.4% | |
| Q4 2025 | -10.1% | -13.2% | -4.3% | |
| Q3 2025 | +36.0% | +29.0% | +9.8% | |
| Q4 2024 | +17.5% | +18.1% | +25.2% | |
| Q3 2024 | +4.3% | +5.9% | +1.9% | |
| Q2 2024 | +13.1% | +20.6% | +16.3% | |
| Q1 2024 | -26.6% | -30.9% | -31.6% | |
| Q4 2023 | -6.4% | -6.2% | -5.2% | |
| Q3 2023 | -14.9% | -11.0% | -22.0% | |
| Q2 2023 | +45.6% | +36.6% | +48.5% | |
| Q1 2023 | -11.1% | -13.1% | -22.2% | |
| Q4 2020 | +3.2% | +4.7% | +22.3% | |
| Q4 2022 | -8.1% | -4.3% | -1.9% | |
| Q3 2021 | +21.1% | +13.9% | -6.8% | |
| Q3 2022 | +27.3% | +16.1% | +2.9% | |
| Q2 2021 | +0.2% | -7.5% | -29.5% | |
| Q2 2022 | +1.4% | +3.4% | -19.1% | |
| Q4 2021 | +8.0% | +7.8% | +44.9% | |
| Q1 2022 | +31.5% | +41.9% | +89.2% | |
| Q1 2021 | — | — | — | |
| Q3 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro